A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...
Biomedical engineer Chethan Pandarinath collaborates with neurosurgeons and scientists across the country in a massive project to help patients with ALS or stroke damage reconnect with the world.
OpenAI has become the lead investor in Merge Labs, a new brain-computer interface research lab co-founded by Sam Altman that just raised around $250 million USD in seed funding Merge Labs is ...
Hosted on MSN
Neuralink and the merging of brain with machine
The curious minds at ColdFusion examine how Neuralink’s brain tech is raising major questions. China issues new Greenland warning to Trump administration Newly released video shows Minneapolis ...
Neuralink to kick-start 'high-volume production' of brain-computer interface devices, Elon Musk says
Elon Musk’s Neuralink is shifting into high gear for 2026 as the company’s co-founder touts changes to the brain-computer interface devices' production. Writing on his social media platform X, Musk ...
BENGALURU, Dec 31 (Reuters) - Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and move to an entirely automated surgical procedure ...
An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...
The Boston-based company's Neurable AI offering uses brain-signal processing technology to integrate brain-computer interface capabilities into devices people use daily. Neurable also offers the MW75 ...
OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...
Succinylation, a nexus between metabolism and epigenetic regulation, is a central factor in the onset and progression of neurodegenerative diseases (NDDs). Research has demonstrated a close ...
After achieving early breakthroughs in materials development, in vitro nanoparticle stimulation and signal reading, Subsense secures additional $10 million to accelerate product development and ...
Accurately and efficiently capturing large-scale neural signals is a core objective of next-generation brain-machine interface (BMI) technology, as well as a critical breakthrough direction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results